![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmÃnticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 14 May 2012 19:40:45
Recent Performance Review For 6 Large-Cap Drug Makers Yielding Over 4%Recent Performance Review For 6 Large-Cap Drug Makers Yielding Over 4% Seeking Alpha The firm has sought out acquisitions to offset patent losses, including the forthcoming expirations of Seroquel and Arimidex . See a recent performance chart for AZN: The best performing listed equity over the last year was LLY, which also has issues ...
08 May 2012 19:46:36
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionIncreased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction MarketWatch (press release) Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole ( Arimidex ), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib, ...
08 May 2012 14:12:47
An object clause is not necessarily determinative of the promise of the patentAn object clause is not necessarily determinative of the promise of the patent Lexology (registration) ... Medicines (Notice of Compliance) Regulations, prohibiting the Minister of Health from issuing a Notice of Compliance to Mylan to sell its generic version of AstraZeneca's ARIMIDEX Â (anastrozole) until after the expiry of Canadian Patent No.
04 May 2012 11:06:14
Canada: Federal Court of Appeal upholds compound claim based on a promise of ...Canada: Federal Court of Appeal upholds compound claim based on a promise of ... Lexology (registration) Nature of case: Appeal from an order of prohibition under s. 6 of the PM(NOC) Regulations On April 11, 2012, the Federal Court of Appeal (â Court of Appealâ ) dismissed an appeal by Mylan Pharmaceuticals ULC (â Mylanâ ) from a decision of Justice Rennie ...
27 Apr 2012 19:03:45
Weak 1Q at AstraZeneca, CEO Quits - Analyst BlogWeak 1Q at AstraZeneca, CEO Quits - Analyst Blog NASDAQ The drugs facing generic competition include Seroquel IR (down 25% to $754 million), Nexium (down 18% to $953 million), Arimidex (down 39% to $144 million), Seloken Toprol-XL (down 8% to $224 million), Casodex (down 17% to $113 million) and Merrem ...
26 Apr 2012 21:34:58
AstraZeneca CEO Brennan bails The Deal Pipeline AstraZeneca CEO Brennan bails The Deal Pipeline AstraZeneca has yet to feel the true impact of Seroquel generics, but generics have already begun pecking away at other key brands such as asthma drug Pulmicort Respules, cancer treatments Casodex and Arimidex , appendicitis and peritonitis injection ... Brennan leaves AstraZeneca, quarterly sales down 11% CEO Brennan to leave AstraZeneca as profits sink Boss of AstraZeneca to step down26 Apr 2012 11:06:10
AstraZeneca CEO Decides To Quit As Profit Falls, Guidance Cut RTT News AstraZeneca CEO Decides To Quit As Profit Falls, Guidance Cut RTT News Loss of exclusivity of Seroquel IR, Nexium and Arimidex , accounted for 8 percent decline in revenue. In addition, disposal of Astra Tech last year accounted for 1.7 percent of the revenue decline, the company noted. Brennan said, "The anticipated ... AstraZeneca chief to quit after major fall in profits Boss of AstraZeneca to step down AstraZeneca net falls by 26% to $2.3 billion in Q125 Apr 2012 19:32:15
Thursday preview: Barclays, Astra, Shire and ShellThursday preview: Barclays, Astra, Shire and Shell ShareCast Japanese broker Nomura is going for first quarter EPS of $1.80 and revenue of $7914m, as Astra suffers from the impact of generic versions of its Arimidex and Nexium drugs in the EU, while the disposal of the AstraTech business will also hit revenues.
|
|
Choose Your language:
Pesquisa no site:
Testemunhos
Recebi a minha encomenda esta semana. Muito obrigado. Podem ter certeza que vou fazer outras encomendas!!!!! A minha mulher ficou mais do que surpresa com o resultado e eu.... me senti com 18 anos novamente. MuitÃssimo obrigado. Muito certamente, voltarei a fazer outras encomendas:) - David
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |